Maintenance Therapy With Sunitinib or Observation in Metastatic Pancreatic Cancer: a Phase II Randomized Trial.
Phase of Trial: Phase II
Latest Information Update: 30 Nov 2013
At a glance
- Drugs Sunitinib (Primary)
- Indications Pancreatic cancer
- Focus Biomarker; Pharmacogenomic; Therapeutic Use
- Acronyms PACT-12
- 02 Oct 2012 Pharmacogenomic results presented at the 37th Congress of the European Society of Medical Oncology.
- 05 Jun 2012 Clinical and translational results presented at the 48th Annual Meeting of the American Society of Clinical Oncology.
- 31 Jan 2012 Actual patient number 56 added as reported by ClinicalTrials.gov.